Menu Search

Company Announcements

Universal Health Realty Income Trust

UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS

Consolidated Results of Operations - Three-Month Periods Ended September 30, 2024 and 2023:

KING OF PRUSSIA, Pa. , Oct. 24, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2024, net income was $4.0 million, or $.29 per diluted share, as compared to $3.9 million, or $.28 per diluted share, during the third quarter of 2023.

The increase in our net income of $125,000, or $.01 per diluted share, during the three-month period ended September 30, 2024, as compared to the third quarter of 2023, consisted of the following: (i) an increase of $451,000, or $.03 per diluted share, resulting from an aggregate net increase in the income generated at various properties, partially offset by; (ii) a decrease of $326,000, or $.02 per diluted share, resulting from an increase in interest expense due primarily to an increase in our average outstanding borrowings and a slight increase in our average borrowing rate.

As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO") were $11.3 million, or $.82 per diluted share, during the third quarter of 2024, as compared to $11.2 million, or $.81 per diluted share during the third quarter of 2023. The increase of $124,000, or $.01 per diluted share, was due primarily to the above-mentioned increase in our net income during the third quarter of 2024, as compared to the third quarter of 2023.    

Consolidated Results of Operations - Nine-Month Periods Ended September 30, 2024 and 2023:

For the nine-month period ended September 30, 2024, net income was $14.6 million, or $1.05 per diluted share, as compared to $11.8 million, or $0.85 per diluted share during the first nine months of 2023.

The increase in our net income of $2.8 million, or $.20 per diluted share, during the first nine months of 2024, as compared to the comparable period of 2023, consisted of the following: (i) an increase of $2.5 million, or $.18 per diluted share, resulting from an aggregate net increase in the income generated at various properties; (ii) an increase of $1.9 million, or $.13 per diluted share, resulting from a reduction in the expenses related to our property located in Chicago, Illinois, including $1.1 million from demolition expenses incurred during the first nine months of 2023, and $563,000 related to a property tax reduction recorded during the first nine months of 2024 which related primarily to prior periods, partially offset by; (iii) a decrease of $1.6 million, or $.11 per diluted share, resulting from an increase in interest expense due primarily to increases in our average borrowing rate as well as our average outstanding borrowings.

As calculated on the attached Supplemental Schedule, our FFO were $36.1 million, or $2.61 per diluted share, during the first nine months of 2024, as compared to $33.2 million, or $2.40 per diluted share during the comparable period of 2023. The increase of $2.9 million, or $.21 per diluted share, was due primarily to the above-mentioned increase in our net income during the first nine months of 2024, as compared to the first nine months of 2023.     

Dividend Information:

The third quarter dividend of $.73 per share, or $10.1 million in the aggregate, was declared on September 4, 2024 and paid on September 30, 2024.

Capital Resources Information:

On September 30, 2024, we entered into a second amended and restated credit agreement which increased the borrowing capacity to $425 million (from $375 million previously) and extended the maturity date to September 30, 2028 (from July, 2025 previously).  We have the option to extend the maturity date for up to two additional six-month periods.

At September 30, 2024, we had $347.8 million of borrowings outstanding pursuant to the terms of our $425 million revolving credit agreement and $77.2 million of available borrowing capacity as of that date, net of outstanding borrowings.

Sierra Medical Plaza I:

In March, 2023, construction was substantially completed on the Sierra Medical Plaza I, an 86,000 square foot MOB located in Reno, Nevada. This MOB is located on the campus of the Northern Nevada Sierra Medical Center, a hospital that is owned and operated by a wholly-owned subsidiary of UHS, which was completed and opened during April, 2022. The master flex lease agreement in connection with this building, which commenced in March, 2023 and has a ten-year term scheduled to expire on March 31, 2033, covers approximately 68% of the rentable square feet of the MOB at an initial minimum rent of $1.3 million annually, plus a pro-rata share of the common area maintenance expenses. This master flex lease agreement is subject to reduction based upon the execution of third-party leases. The aggregate cost of the MOB is estimated to be approximately $35 million, approximately $30 million of which was incurred as of September 30, 2024.

Vacant Land/Specialty Facility:

Demolition of the former specialty hospital located in Chicago, Illinois, was completed during 2023. The aggregate demolition expenses amounted to approximately $1.5 million ($1.1 million of which were incurred during the first and second quarters of 2023 and $332,000 of which were incurred during the fourth quarter of 2022). In addition, in December, 2023, we sold the vacant specialty facility located in Corpus Christi, Texas. 

We continue to market the vacant properties located in Chicago, Illinois and Evansville, Indiana. Future operating expenses related to these properties, will be incurred by us during the time they remain owned and unleased.

Financial Instruments:

In October, 2024, we entered into an interest rate swap agreement on a total notional amount of $85 million with a fixed interest rate of 3.2725% that we designated as a cash flow hedge. The interest rate swap became effective on October 2, 2024 and is scheduled to mature on September 30, 2028. If one-month term SOFR is above 3.2725%, the counterparty pays us, and if one-month term SOFR is less than 3.2725%, we pay the counterparty the difference between the fixed rate of 3.2725% and one-month term SOFR.

This interest rate swap agreement replaced two interest rate swaps agreements that expired on September 16, 2024 with a combined aggregate notional amount of $85 million. 

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-six properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7 - Forward-Looking Statements in our Form 10-K for the year ended December 31, 2023 and in Item 7 - Forward-Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended June 30, 2024), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. 

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the shortage of nurses and other clinical staff and support personnel, the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions related to supplies required for our tenants' employees and patients; and potential increases to other expenditures.

In addition, the increase in interest rates has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms.  Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.       

We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains on transactions.

Funds from operations ("FFO") is a widely recognized measure of performance for Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts ("NAREIT"), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented.  FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.

To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2023 and our Report on Form 10-Q for the quarter ended June 30, 2024. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Nine Months Ended September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)










Three Months Ended



Nine Months Ended




September 30,



September 30,




2024



2023



2024



2023


Revenues:













  Lease revenue - UHS facilities (a.)


$

8,248



$

8,274



$

25,366



$

24,297


  Lease revenue - Non-related parties



14,342




13,926




43,188




40,955


  Other revenue - UHS facilities



242




254




682




730


  Other revenue - Non-related parties



305




404




1,056




1,177


  Interest income on financing leases - UHS facilities



1,357




1,365




4,077




4,096





24,494




24,223




74,369




71,255


Expenses:













  Depreciation and amortization



7,009




7,012




20,624




20,479


  Advisory fees to UHS



1,386




1,332




4,093




3,957


  Other operating expenses



7,609




7,854




22,115




23,625





16,004




16,198




46,832




48,061


Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense



8,490




8,025




27,537




23,194


  Equity in income of unconsolidated LLCs



300




314




956




953


  Interest expense, net



(4,793)




(4,467)




(13,920)




(12,340)


Net income


$

3,997



$

3,872



$

14,573



$

11,807


Basic earnings per share


$

0.29



$

0.28



$

1.06



$

0.86


Diluted earnings per share


$

0.29



$

0.28



$

1.05



$

0.85















Weighted average number of shares outstanding - Basic



13,807




13,790




13,799




13,784


Weighted average number of shares outstanding - Diluted



13,849




13,822




13,835




13,811



(a.) Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility, of $765 and $725 for the three-month periods ended September 30, 2024 and 2023, respectively, and $2,306 and $2,219 for the nine-month periods ended September 30, 2024 and 2023, respectively.

 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Three Months Ended  September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)


Calculation of Adjusted Net Income










Three Months Ended



Three Months Ended




September 30, 2024



September 30, 2023




Amount



Per
Diluted Share



Amount



Per
Diluted Share


Net income


$

3,997



$

0.29



$

3,872



$

0.28


Adjustments



-




-




-




-


Subtotal adjustments to net income



-




-




-




-


Adjusted net income


$

3,997



$

0.29



$

3,872



$

0.28



Calculation of Funds From Operations ("FFO")




Three Months Ended



Three Months Ended




September 30, 2024



September 30, 2023




Amount



Per
Diluted Share



Amount



Per
Diluted Share


Net income


$

3,997



$

0.29



$

3,872



$

0.28


Plus: Depreciation and amortization expense:













Consolidated investments



7,009




0.51




7,012




0.51


Unconsolidated affiliates



311




0.02




309




0.02


FFO


$

11,317



$

0.82



$

11,193



$

0.81


Dividend paid per share





$

0.730






$

0.720


 

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")

For the Nine Months Ended September 30, 2024 and 2023

(amounts in thousands, except share information)

(unaudited)


Calculation of Adjusted Net Income










Nine Months Ended



Nine Months Ended




September 30, 2024



September 30, 2023




Amount



Per
Diluted Share



Amount



Per
Diluted Share


Net income


$

14,573



$

1.05



$

11,807



$

0.85


Adjustments



-




-




-




-


Subtotal adjustments to net income



-




-




-




-


Adjusted net income


$

14,573



$

1.05



$

11,807



$

0.85



Calculation of Funds From Operations ("FFO")




Nine Months Ended



Nine Months Ended




September 30, 2024



September 30, 2023




Amount



Per
Diluted Share



Amount



Per
Diluted Share


Net income


$

14,573



$

1.05



$

11,807



$

0.85


Plus: Depreciation and amortization expense:













Consolidated investments



20,624




1.49




20,479




1.48


Unconsolidated affiliates



918




0.07




900




0.07


FFO


$

36,115



$

2.61



$

33,186



$

2.40


Dividend paid per share





$

2.185






$

2.155


 

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)




September 30,



December 31,




2024



2023


Assets:







Real Estate Investments:







Buildings and improvements and construction in progress


$

654,154



$

649,374


Accumulated depreciation



(280,859)




(262,449)





373,295




386,925


Land



56,870




56,870


               Net Real Estate Investments



430,165




443,795


Financing receivable from UHS



82,921




83,279


               Net Real Estate Investments and Financing receivable



513,086




527,074


Investments in limited liability companies ("LLCs")



14,260




9,102


Other Assets:







Cash and cash equivalents



6,372




8,212


Lease and other receivables from UHS



6,995




6,180


Lease receivable - other



8,580




8,166


Intangible assets (net of accumulated amortization of $11.9 million and
   $12.5 million, respectively)



7,758




9,110


Right-of-use land assets, net



10,925




10,946


Deferred charges, notes receivable and other assets, net



16,354




17,579


               Total Assets


$

584,330



$

596,369


Liabilities:







Line of credit borrowings


$

347,750



$

326,600


Mortgage notes payable, non-recourse to us, net



19,662




32,863


Accrued interest



736




490


Accrued expenses and other liabilities



12,690




13,500


Ground lease liabilities, net



10,925




10,946


Tenant reserves, deposits and deferred and prepaid rents



10,928




11,036


               Total Liabilities



402,691




395,435


Equity:







Preferred shares of beneficial interest,
   $.01 par value; 5,000,000 shares authorized;
   none issued and outstanding



-




-


Common shares, $.01 par value;
   95,000,000 shares authorized; issued and outstanding: 2024 - 13,849,424;
   2023 - 13,823,899



138




138


Capital in excess of par value



270,826




270,398


Cumulative net income



840,634




826,061


Cumulative dividends



(933,216)




(902,975)


Accumulated other comprehensive income



3,257




7,312


     Total Equity



181,639




200,934


               Total Liabilities and Equity


$

584,330



$

596,369


 

Cision View original content:https://www.prnewswire.com/news-releases/universal-health-realty-income-trust-reports-2024-third-quarter-financial-results-302286522.html

SOURCE Universal Health Realty Income Trust